These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 19214765

  • 1. A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.
    Mabeta P, Pepper MS.
    Angiogenesis; 2009; 12(1):81-90. PubMed ID: 19214765
    [Abstract] [Full Text] [Related]

  • 2. [Novobiocin inhibits angiogenesis and shows synergistic effect with vincristine].
    Yang J, Jiang M, Zhen YS.
    Yao Xue Xue Bao; 2003 Oct; 38(10):731-4. PubMed ID: 14730893
    [Abstract] [Full Text] [Related]

  • 3. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells.
    Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, Deepak V, Muniyandi J, Eom SH, Gurunathan S.
    Colloids Surf B Biointerfaces; 2009 Oct 01; 73(1):51-7. PubMed ID: 19481908
    [Abstract] [Full Text] [Related]

  • 4. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
    Hayot C, Farinelle S, De Decker R, Decaestecker C, Darro F, Kiss R, Van Damme M.
    Int J Oncol; 2002 Aug 01; 21(2):417-25. PubMed ID: 12118340
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
    Scott AN, Hetheridge C, Reynolds AR, Nayak V, Hodivala-Dilke K, Mellor H.
    Angiogenesis; 2008 Aug 01; 11(4):337-46. PubMed ID: 18758974
    [Abstract] [Full Text] [Related]

  • 9. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
    Chen HM, Yan XJ, Wang F, Lin J, Xu WF.
    Yao Xue Xue Bao; 2007 Jun 01; 42(6):595-600. PubMed ID: 17702394
    [Abstract] [Full Text] [Related]

  • 10. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
    Kruczynski A, Poli M, Dossi R, Chazottes E, Berrichon G, Ricome C, Giavazzi R, Hill BT, Taraboletti G.
    Eur J Cancer; 2006 Nov 01; 42(16):2821-32. PubMed ID: 16973349
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M, Truax R, Stout R, Portier R, Losso JN.
    J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359
    [Abstract] [Full Text] [Related]

  • 12. Structure and anti-proliferation function of 5,5-diphenyl-2-thiohydantoin (DPTH) derivatives in vascular endothelial cells.
    Cheng CK, Wu J, Liu Y, Lee TS, Kang SJ, Sheu MT, Lee WS.
    Vascul Pharmacol; 2008 Jun 24; 48(2-3):138-42. PubMed ID: 18295547
    [Abstract] [Full Text] [Related]

  • 13. Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action.
    Issekutz AC, Sapru K.
    Int Immunopharmacol; 2008 May 24; 8(5):708-16. PubMed ID: 18387513
    [Abstract] [Full Text] [Related]

  • 14. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B, Kürti L, Mammoto A, Ingber DE, Corey EJ.
    J Am Chem Soc; 2009 Jul 01; 131(25):9014-9. PubMed ID: 19469509
    [Abstract] [Full Text] [Related]

  • 15. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P, Gourni D, Aplin AC, Nicosia RF, Flordellis CS, Maragoudakis ME, Tsopanoglou NE.
    J Pharmacol Exp Ther; 2009 Feb 01; 328(2):378-89. PubMed ID: 18988770
    [Abstract] [Full Text] [Related]

  • 16. Synergistic enhancement of apoptosis by DNA- and cytoskeleton-damaging agents: a basis for combination chemotherapy of cancer.
    Shang X, Shiono Y, Fujita Y, Oka S, Yamazaki Y.
    Anticancer Res; 2001 Feb 01; 21(4A):2585-9. PubMed ID: 11724325
    [Abstract] [Full Text] [Related]

  • 17. Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis.
    Stafford SJ, Schwimer J, Anthony CT, Thomson JL, Wang YZ, Woltering EA.
    J Surg Res; 2005 May 01; 125(1):104-8. PubMed ID: 15836858
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comments on "Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis".
    Di Serio C, Pellerito S, Tarantini F.
    J Pharmacol Exp Ther; 2008 Jan 01; 324(1):404-5; author reply 406-7. PubMed ID: 18094323
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.